Trial intelligence / Profile preview

Hydrocortisone for thrombosis and depression in TKA

NCT01815918Phase 4Completed

Sponsor
Hospital for Special Surgery
Start
Feb 2011
Primary completion
Apr 2012
Countries
1
01

Overview

A Phase 4 trial of hydrocortisone in thrombosis, major depressive disorder (MDD), sponsored by Hospital for Special Surgery. Started Feb 2011; status: completed.

02

Drugs

hydrocortisone
03

Conditions

thrombosismajor depressive disorder (MDD)

Beyond the preview

Go deeper on NCT01815918.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01815918.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call